Evidence map›Paper›PMID 36902379›Full record

ArticleInternational journal of molecular sciences2023

Morgane De Tollenaere, Emilie Chapuis, Jessy Martinez, Chantal Paulus, Joran Dupont, Eglantine Don Simoni, Patrick Robe, Bénédicte Sennelier-Portet, Daniel Auriol, Amandine Scandolera and 1 more

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Morgane De TollenaereR&D Department, Givaudan France SAS, Route de Bazancourt, 51110 Pomacle, France.ORCID 0000-0001-8283-7864
Emilie ChapuisR&D Department, Givaudan France SAS, Route de Bazancourt, 51110 Pomacle, France.
Jessy MartinezR&D Department, Naturex France Avignon (Givaudan), 250 Rue Pierre Bayle, 84140 Avignon, France.
Chantal PaulusR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.
Joran DupontR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.
Eglantine Don SimoniR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.
Patrick RobeR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.ORCID 0000-0002-9102-7801
Bénédicte Sennelier-PortetR&D Department, Naturex France Avignon (Givaudan), 250 Rue Pierre Bayle, 84140 Avignon, France.
Daniel AuriolR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.
Amandine ScandoleraR&D Department, Givaudan France SAS, Route de Bazancourt, 51110 Pomacle, France.ORCID 0000-0001-6403-1664
Romain ReynaudR&D Department, Givaudan France SAS, Bâtiment Canal Biotech 1, 3 Rue des Satellites, 31400 Toulouse, France.ORCID 0000-0001-5417-5357
Givaudan (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Digital stress is a newly identified cosmetic stress that is mainly characterized by blue light exposure. The effects of this stress have become increasingly important with the emergence of personal digital devices, and its deleterious effects on the body are now well-known. Blue light has been observed to cause perturbation of the natural melatonin cycle and skin damage similar to that from UVA exposure, thus leading to premature aging. "A melatonin-like ingredient" was discovered in the extract of

Indexed as

Aging, PrematureGardeniaMelatoninCells, CulturedHumansSkinMelatoninagingblue lightcrocetin–microbiotacrocindigital stressGardenia jasminoides fruit extractmelatoninskin

Identifiers

PMID36902379
PMCPMC10003113
OpenAlexW4323318316

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read101
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.